Guardian Pharmacy Services Income Statement (2023-2026) | GRDN

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter) 262.74M281.07M275.41M300.04M314.39M338.57M329.31M344.33M377.43M397.62M336.60M351.77M
Cost of Revenue (Quarter) 210.55M226.49M220.31M238.75M253.51M271.46M264.96M276.19M302.71M312.11M260.29M271.72M
Gross Profit (Quarter) 52.19M54.58M55.10M61.29M60.88M67.10M64.35M68.15M74.72M85.50M76.31M80.04M
Operating items
Selling, General & Administrative (Quarter) 58.52M39.05M47.17M44.28M165.49M50.35M51.34M55.57M58.37M54.74M58.63M59.40M
Operating Expenses (Quarter) 58.52M39.05M47.17M44.28M165.49M50.35M51.34M55.57M58.37M54.74M58.63M59.40M
Operating Income (Quarter) -6.33M15.52M7.93M17.00M-104.61M16.75M13.01M12.58M16.35M30.76M17.68M20.64M
EBIT (Quarter) -6.33M15.52M7.93M17.00M-104.61M16.75M13.01M12.58M16.35M30.76M17.68M20.64M
Non-operating items
Other Non Operating Income (Quarter) 0.05M-0.23M-0.07M-0.09M-0.00M-0.11M0.27M0.18M0.44M0.50M0.77M9.30M
Non Operating Income (Quarter) -0.67M-0.96M-0.84M-1.16M-1.03M-0.53M0.10M0.01M0.28M0.34M0.62M9.15M
Net income details
EBT (Quarter) -7.00M14.56M7.09M15.85M-105.64M16.22M13.11M12.59M16.63M31.10M18.29M29.79M
Tax Provisions (Quarter) 0.18M4.38M3.83M3.76M7.04M9.83M4.75M7.67M
Profit After Tax (Quarter) -7.00M14.56M7.09M15.85M-105.82M11.94M9.45M9.03M9.82M20.66M13.29M22.12M
Income from Non-Controlling Interests (Quarter) 4.29M2.54M4.31M5.22M6.82M-0.10M-0.17M-0.20M-0.23M0.34M0.25M0.25M
Income from Continuing Operations (Quarter) -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M21.27M13.54M22.12M
Consolidated Net Income (Quarter) -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M21.27M13.54M22.12M
Income towards Parent Company (Quarter) -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M21.27M13.54M22.12M
Net Income towards Common Stockholders (Quarter) -7.00M14.56M7.09M15.85M-105.82M11.84M9.27M8.83M9.59M21.27M13.54M22.12M
Additional items
EPS (Basic) (Quarter) -1.730.190.150.140.150.34213.89349.31
EPS (Diluted) (Quarter) -1.730.190.150.140.150.34212.65346.53
Shares Outstanding (Quarter) 61.14M62.01M62.04M62.05M62.12M62.39M0.06M0.06M
Shares Outstanding (Diluted) (Quarter) 61.14M62.01M62.91M63.20M63.43M63.30M0.06M0.06M
Shares Outstanding (Entity) (Quarter) 54.09M54.09M62.04M62.05M62.12M62.39M0.06M0.06M
EBITDA (Quarter) -6.33M15.52M7.93M17.00M-104.61M16.75M13.01M12.58M16.35M30.76M17.68M20.64M
Interest Expenses (Quarter) 0.72M0.74M0.77M1.07M1.03M0.43M0.17M0.17M0.16M11.34M0.15M0.15M
Tax Rate (Quarter) -0.17%27.00%29.25%29.87%42.32%31.62%25.96%25.75%